Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
EuroPCR 25: The TRICURE EU Study
Author(s): Julien Dreyfus Added: 1 month ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating… View more

Intervention
NY Valves 25: TRISCEND II Substudy
Author(s): Added: 2 weeks ago
New York Valves 25 - A substudy of TRISCEND II investigating the effect of transcatheter tricuspid valve replacement (TTVR) on preference-weighted health status showed significant benefits in patients who received TTVR.We are joined by Dr Suzanne Arnold (Saint Luke's Mid America Heart Institute, US) to discuss the findings from a substudy of the TRISCEND II trial, which aimed to create an… View more

Intervention
EuroPCR 25: The TRINITY Trial
Author(s): Thomas Modine Added: 1 month ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement… View more

Heart Failure

Intervention
TCT 24: The TRISCEND II Trial
Author(s): Susheel Kodali Added: 8 months ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter tricuspid valve replacement (TTVR) compared to optimal medical therapy for patients with severe tricuspid regurgitation (TR).Dr Susheel Kodali (Columbia University Medical Center, New York, US) joins us onsite at TCT Conference to discuss the findings from the TRISCEND II Trial (NCT04482062; Edwards Lifesciences).TRISCEND II is a… View more

Intervention
Tricuspid Regurgitation Therapy
Author(s): Qiuyu Martin Zhu , Natalia Berry Added: 1 year ago

Heart Failure
Atrioventricular (AV) Valves Summit 2024
Author(s): Marco Metra , Victoria Delgado , Nicole Karam , et al Added: 8 months ago
In this series of short interviews filmed at AV Valves Summit 2024, leading experts offer valuable insights and professional opinions on transcatheter mitral and tricuspid interventions.The sessions explore a wide array of topics, including advancements in TEER techniques, the evolving focus on patient quality of life, the ongoing debate between repair versus replacement, and the most effective… View more

Vascular Disease and Surgery
New York Valves 2025
Author(s): Paul Grayburn Added: 3 weeks ago
Don't miss our late-breaking coverage of New York Valves 2025 Summit, including Expert Interviews offering insights into key data and their future impact on clinical practice. View more

Imaging & Diagnostics

Intervention
Unusual Presentations of Thyrotoxic Valvulopathy in Adult Thyrotoxicosis
Author(s): Andro Pramana Witarto , Bendix Samarta Witarto , Shidi Laras Pramudito , et al Added: 11 months ago

Imaging & Diagnostics

Prevention & Chronic Conditions
Atrioventricular (AV) Valves Summit 2023
Author(s): , Added: 1 year ago
In this series of short interviews and discussions filmed at AV Valves Summit 2023, the faculty delve into sharing invaluable insights and expert opinion on transcathetermitral and tricuspid intervention. They examine a range of topics which include the development of TEER, the importance of quality of life, repair vs replacement and how to best shape the future of MR and TR treatment. The AV… View more

Imaging & Diagnostics

Intervention
EuroPCR 25: The FATE Registry
Author(s): Fedrico de Marco Added: 1 month ago
EuroPCR 2025 - Outcomes from the FATE Registry show coapttion gaps are at the upper limit of treatability in this patient group using current tTEER devices.Dr Fedrico de Marco (Centro Cardiologico Monzino IRCCS, Milan, IT) joins us to discuss the management and outcomes from the FATE registry, which investigated 123 case of failed tricuspid transcatheter edge-to-edge repair (tTEER) with all… View more

Intervention